Nurix Therapeutics (NRIX) revenue breakdown
By product, Collaboration revenue is the largest at 64% of fiscal 2025 revenue; License revenue grew fastest, 50% a year over 1 years.
Revenue by product
Fiscal years, as Nurix Therapeutics reports them in its 10-K filings; fiscal 2025 total $84M.
| Products | 2023 | 2025 | Share |
|---|---|---|---|
| Collaboration revenue | $57M | $54M | 64% |
| License revenue | $20M | $30M | 36% |
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for NRIX.
Open NRIX in InvestinglyQuestions
Where does Nurix Therapeutics make its money?
In fiscal 2025, by product: Collaboration revenue $54M, License revenue $30M.
From Nurix Therapeutics's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.